TSE:CLS

Celestica Inc (CLS.TO)

470.91
-2.12 (0.45%)
as of Jul 23, 2026, 8:00:01 pm Market Open.
208 watching
0
Investor Insights
star iconJul 23, 2026, 12:00 am

This summary was created by AI, based on 33 opinions in the last 12 months.

Celestica Inc (CLS-T) has garnered mixed reviews from various experts, primarily focused on its role in the burgeoning AI and cloud infrastructure markets. Many are optimistic about the company's potential for revenue growth, citing impressive quarterly gains exceeding 50% and an upbeat outlook for the coming years, which could see earnings per share escalate significantly. However, some analysts caution against the high price-to-earnings (PE) multiple, suggesting the stock is overpriced given its manufacturing background, leading to volatility concerns. The general sentiment leans towards holding or cautiously purchasing on dips, reflecting both the stock's recent volatility and the growing importance of AI infrastructure. While a handful suggest profit-taking given the stock's substantial run-up, most agree Celestica will continue to be significant in the tech space.

consensus icon
Consensus
Hold
valuation icon
Valuation
Overvalued
review icon
Similar
AVGO
BUY

Lots of opportunity. Ability to monetize AI has really helped customers. Going gangbusters. Runway is far out, both on fundamentals and on price.

WAIT

He's wanted to own this for a while. They provide supply chain solutions, which is topical. Now, the price is too rich. Earnings are coming up, so wait for that. 

HOLD

An amazing chart, but be cautious adding at current levels.

BUY ON WEAKNESS
Bought at $50, $70, and $134.

Definitely volume on this name. Note that the recent move is parabolic. So you want to look at the stock over its 200-day MA; don't want to see much more than 15%. 15-20% over the 200-day is getting into overbought territory.

Up is good and down is bad, but when you see this kind of an up, expect a pullback. So you draw a new trendline, and the stock will probably retrace close to (if not actually right to) it. A reasonable retracement level might be $110-120, but this is not an iron-clad prediction. Overall trend is up, doesn't see a problem with the chart.

BUY

Solid fundamentals. Healthcare solutions will pay dividends going forward. Not a bad valuation for a long-term play over the next 5 years. 

HOLD
An unbelievable 800% over the past 3 years.

Can't really do technical analysis on a chart like this, as there's no real pattern that's taking place. Doesn't think year-end profit-taking will weigh on the stock.

HOLD
Bought at $48, again at $70.

Pitfalls would include chasing or buying too much. Other risks are not following it and not having a plan. Acceleration is really strong. Good volume along with the buying, which is supportive. Reaching a bit of a limit right now, which may be profit taking, and may pull back to $110. A drop below $105 with a full position is a problem.

Unspecified

It has changed a lot and starting to focus more on helping clients develop new projects. It is riding the AI boom and has just passed the old high from23 years ago. Has had a very low multiple for a long time. It has started to execute better, grow faster and meet expectations. It is quite cheap in terms of tech stocks and should do quite well from a momentum standpoint.

WAIT

Probably overbought here, up 240% in last 12 months. 21-22x forward earnings, 15-16% EPS growth rate. Not really expensive. Likes it.

SELL

Keeps going up. Business has totally morphed into value-added parts in the semiconductor space. Riding the wave of massive growth of all chipmakers. Valuation seems reasonable. Remember that semis are cyclical; ASML, for example, went down 20% yesterday. Hot stocks always have potential to re-rate.

Quite well run, but not ready to be there. His preference is TSM, but its valuation is not attractive either.

BUY

He wished he owned this. It's had a big move and is breaking out into new highs. A good momentum play.

HOLD

Trending higher above the 200-day MA, which itself is moving higher. Watch it in terms of how far the valuation goes. Right now, 15x forward earnings with about a 13% growth rate for 2025, 29% for 2026. Valuation is actually not as expensive as a lot of other tech names, especially in the US. Valuation and technicals look decent.

SELL

Broke trend, rallied, but made a lower high. Now making a lower low. He has a very low weight in tech, about 12%; whereas the S&P is about 28-29%. So many other things to do that are less crowded than tech. Technical setup not great; background for tech not as good as it was.

PARTIAL BUY

12-month price target of $79, still a bit of room. On the chart, you can see the highs that go back to the early summer. Buy 1/3 here around $68, another at just under $64 where there seems to be some support, and the final 1/3 at just over $60. Put in a stop around $54-55.

Concentration risk, but its manufacturing and platform solutions are state of the art. Client base includes hyperscalers and service providers. Extremely well run.

RISKY

Wished he bought it a year ago. Have very low margins, but now benefit from supplying equipment to hyperscalers. They hugely depend on one client, though, in their AI-related, data centre business. Can be very volatile. Careful. Take profits if you've made money here. 

Showing 61 to 75 of 567 entries